Sanofi earns break­through nod in he­mo­phil­ia A as it con­tin­ues to play catch-up with Roche's Hem­li­bra

As Sanofi pre­pares to present its he­mo­phil­ia A pitch to the FDA, reg­u­la­tors are ac­knowl­edg­ing the po­ten­tial of the Big Phar­ma’s ex­per­i­men­tal drug.

The agency …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER